Nanjing Historical Cash Flow
| 688273 Stock | 26.05 0.22 0.85% |
Analysis of Nanjing Medlander cash flow over time is an excellent tool to project Nanjing Medlander Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 74.7 M or Change In Working Capital of 34.5 M as it is a great indicator of Nanjing Medlander ability to facilitate future growth, repay debt on time or pay out dividends.
Nanjing |
About Nanjing Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Nanjing balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Nanjing's non-liquid assets can be easily converted into cash.
Nanjing Medlander Cash Flow Chart
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of Nanjing Medlander Medical value has been used up. For tax purposes Nanjing Medlander can deduct the cost of the tangible assets it purchases as business expenses. However, Nanjing Medlander Medical must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Nanjing Medlander's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Nanjing Medlander Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Nanjing Medlander Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Nanjing Medlander's Change To Inventory is projected to decrease significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 74.7 M, whereas Investments are projected to grow to (225.6 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Other Non Cash Items | 1.9M | 3.4M | 2.7M | 2.6M | Depreciation | 11.4M | 14.5M | 17.8M | 13.8M |
Nanjing Medlander cash flow statement Correlations
Click cells to compare fundamentals
Nanjing Medlander Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
Other Information on Investing in Nanjing Stock
The Cash Flow Statement is a financial statement that shows how changes in Nanjing balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Nanjing's non-liquid assets can be easily converted into cash.